1. Antivascular therapy of cancer: DMXAA;Baguley;Lancet Oncol.,2003
2. Induction of tumour necrosis factor-alpha by single and repeated doses of the antitumour agent 5,6-dimethylxanthenone-4-acetic acid;Philpott;Cancer Chemother. Pharmacol.,1995
3. Activation of LPS-inducible genes by the antitumor agent 5,6-dimethylxanthenone-4-acetic acid in primary murine macrophages—dissection of signaling pathways leading to gene induction and tyrosine phosphorylation;Perera;J. Immunol.,1994
4. Interferon-inducible protein 10 induction and inhibition of angiogenesis in vivo by the antitumor agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA);Cao;Cancer Res,2001
5. Suppression of serum tumour necrosis factor-alpha by thalidomide does not lead to reversal of tumour vascular collapse and anti-tumour activity of 5,6-dimethylxanthenone-4-acetic acid;Browne;Anticancer Res.,1998